Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer culturesResearch in context
Summary: Background: Pancreatic ductal adenocarcinoma (PDAC) is a tumour entity with unmet medical need.To assess Mat the therapeutic potential of oncolytic virotherapy (OVT) against PDAC, different oncolytic viruses (OVs) are currently investigated in clinical trials.However, systematic comparisons of these different OVs in terms of efficacy again